Patrick Magahis, MD (@PatrickMagahis) profile picture

Resident @BrighamMedRes | MD @WeillCornell | AB @Harvard | Interests: gastroenterology, advanced endoscopy, EndoHepatology

Joined May 2024
Photo by Patrick Magahis, MD (@PatrickMagahis)Photo by Patrick Magahis, MD (@PatrickMagahis)
Incredibly grateful to have matched at @BrighamMedRes for Internal Medicine residency! Excited to be heading back to Boston for this next step in my training. Everything owed to my family and mentors at @WeillCornell + @MSKCancerCenter for their unconditional support. #Match2025
1
1
24
3,739
Patrick Magahis, MD retweeted
Out now in @EndoscopyJrnl: a cost-effectiveness analysis of EUS-CDS with LAMS vs ERCP-BD with SEMS for primary palliation of malignant distal biliary obstruction. Markov model, US payer perspective, 1yr horizon. ICER $47,711/QALY. Cost-effective when CBD >15 mm. @PatrickMagahis
EUS-CDS vs. ERCP-BD for primary palliation of malignant distal biliary obstruction: a cost–effectiveness modeling analysis Find the article at: doi.org/10.1055/a-2837-1405 Patrick T. Magahis et al. #Endoscopy #Gastroenterology @ESGE_news @PatrickMagahis @ReemSharaiha
1
8
966
Happy to share our newest paper comparing #EUS vs #ERCP for #MDBO: 💰EUS cost-effective over ERCP (ICER $47k) ✅ Driven by ⬇️ initial cost (despite LAMS), ⬇️ reintervention rates, ⬇️ pancreatitis, ⬆️ technical success. 📊 Robust on sensitivity analyses, hospital-level analysis
EUS-CDS vs. ERCP-BD for primary palliation of malignant distal biliary obstruction: a cost–effectiveness modeling analysis Find the article at: doi.org/10.1055/a-2837-1405 Patrick T. Magahis et al. #Endoscopy #Gastroenterology @ESGE_news @PatrickMagahis @ReemSharaiha
1
1
3
325
🤔 Anatomy, expertise, patient risk factors should still drive drainage modality 💭 RCTs comparing EUS vs ERCP in all comers with MDBO critically needed 🏋️ Expanding therapeutic EUS training/accessibility is essential Thank you to my mentors @ReemSharaiha and #SriHariMahadev!
1
49
Thank you @ASGEendoscopy and @DDWMeeting for allowing us to present our work on developing and validating an EUS liver model for training in endohepatology! #DDW2026
6
28
2,261
Patrick Magahis, MD retweeted
Magahis et al compare "Outcomes of endoscopic ultrasound–guided liver biopsy using 22-gauge versus 19-gauge needles with a novel hydrostatic sampling technique." giejournal.org/article/S0016… #GITwitter @PatrickMagahis @ReemSharaiha @MarkHanscomMD
5
13
1,368
Patrick Magahis, MD retweeted
Drs Patrick T. Magahis and SriHari Mahadev discuss “Outcomes of endoscopic ultrasound–guided liver biopsy using 22-gauge versus 19-gauge needles with a novel hydrostatic sampling technique." youtu.be/cFEn4tbjCuI #GITwitter @PatrickMagahis @ReemSharaiha @MarkHanscomMD
4
13
1,120
Patrick Magahis, MD retweeted
Online now in GIE’s Articles in Press: "Outcomes of EUS-guided liver biopsy using 22-gauge versus 19-gauge needles with a novel hydrostatic sampling technique" by Patrick T. Magahis et al. giejournal.org/article/S0016… #GITwitter @PatrickMagahis @MarkHanscomMD @ReemSharaiha
1
2
8
1,282
Happy to share our recent @JNCCN study on #Cdiff infection in patients on #immunotherapy p/w diarrhea: 👉Common (18%) 👉⬆️G3-4 diarrhea but antibiotic tx alone sufficient for most 👉24% required steroids for concomitant immune-related enterocolitis (1/2) doi.org/10.6004/jnccn.2024.7…
1
1
1
1
3,599
🔑 Prompt CDI testing for all ➡️ if +, abx + close f/up ➡️ if persistent sx, endoscopy + consider steroids for concomitant irEC Thank you to my mentor and study PI @DavidFaleckMD + all our @MSKCancerCenter co-authors @MLaszkowskaMD @DeepikaSatishMD @mini_kamboj @EBabady! (2/2)
2
271
Patrick Magahis, MD retweeted
55M w/ UC x30y. Prior 5-ASA, 6MP. On IFX 5 mg/kg q8w x5y. Mild UC sx before infusions. 🔦Last scope 1y ago: Mayo 0. Now FCP 141, IFX level 3. New dx: metastatic melanoma → onc is starting nivolumab. What do you recommend for his UC?
17%Stop IFX, monitor on Nivo
37%⬆️IFX 5mg/kg q4wks+Nivo
5%Stop IFX, start Upa+Nivo
41%Stop IFX, start VDZ+Nivo
87 votes • Final results
4
13
15
2,818
So excited for this all-star intern crew to join us in June!! Huge congratulations on a fantastic and well-deserved #match2025! 🎉
3
16
7
107
38,309
Patrick Magahis, MD retweeted
Congratulations to @PatrickMagahis @AnkitChhoda and the rest of the team for their recent publication in ACG on the risk of pancreatitis after EUS-FNA! 🔑 The pooled risk of pancreatitis was 1.4% after EUS-FNA, most cases of which (67%) were mild. journals.lww.com/ajg/fulltex…
1
4
404
Here’s a closer look at recent #JITC article “Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors” by @PatrickMagahis & @DavidFaleckMD from @WeillCornell & @MSKCancerCenter. 1/11
1
2
4
759
Patrick Magahis, MD retweeted
Happy to share our experience using open capsule budesonide for successful treatment of immune-related enteritis. Grateful for my fantastic team @MSKCancerCenter who help treat these pts and made this study possible and ⭐️ med student @PatrickMagahis for putting this together.
New #JITC article: Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors bit.ly/4daLo9Z @PatrickMagahis @DavidFaleckMD
2
10
3,984
New #JITC article: Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors bit.ly/4daLo9Z @PatrickMagahis @DavidFaleckMD
1
1
2
4,783